Schonfeld Strategic Advisors’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.7M | Sell |
449,206
-111,153
| -20% | -$4.39M | 0.12% | 169 |
|
|
2025
Q1 | $16.9M | Buy |
560,359
+188,978
| +51% | +$5.7M | 0.1% | 172 |
|
|
2024
Q4 | $13M | Buy |
371,381
+8,493
| +2% | +$297K | 0.08% | 224 |
|
|
2024
Q3 | $14.5M | Sell |
362,888
-360,730
| -50% | -$14.5M | 0.1% | 175 |
|
|
2024
Q2 | $34.5M | Buy |
723,618
+552,758
| +324% | +$26.3M | 0.22% | 65 |
|
|
2024
Q1 | $7.41M | Sell |
170,860
-142,414
| -45% | -$6.17M | 0.05% | 419 |
|
|
2023
Q4 | $15.8M | Buy |
313,274
+251,726
| +409% | +$12.7M | 0.11% | 197 |
|
|
2023
Q3 | $2.79M | Buy |
61,548
+22,504
| +58% | +$1.02M | 0.02% | 614 |
|
|
2023
Q2 | $1.6M | Sell |
39,044
-3,165
| -7% | -$130K | 0.01% | 821 |
|
|
2023
Q1 | $1.51M | Sell |
42,209
-223,589
| -84% | -$7.99M | 0.01% | 775 |
|
|
2022
Q4 | $10M | Buy |
265,798
+58,126
| +28% | +$2.2M | 0.08% | 302 |
|
|
2022
Q3 | $9.19M | Buy |
207,672
+77,649
| +60% | +$3.43M | 0.08% | 338 |
|
|
2022
Q2 | $4.81M | Buy |
130,023
+74,480
| +134% | +$2.76M | 0.05% | 447 |
|
|
2022
Q1 | $2.06M | Buy |
+55,543
| New | +$2.06M | 0.02% | 676 |
|
|
2021
Q2 | – | Sell |
-21,101
| Closed | -$948K | – | 2060 |
|
|
2021
Q1 | $948K | Buy |
21,101
+5,966
| +39% | +$268K | 0.01% | 879 |
|
|
2020
Q4 | $855K | Buy |
+15,135
| New | +$855K | 0.01% | 827 |
|
|
2020
Q2 | – | Sell |
-12,436
| Closed | -$588K | – | 1337 |
|
|
2020
Q1 | $588K | Buy |
+12,436
| New | +$588K | 0.04% | 527 |
|
|
2017
Q2 | – | Sell |
-10,431
| Closed | -$419K | – | 670 |
|
|
2017
Q1 | $419K | Sell |
10,431
-9,569
| -48% | -$384K | 0.04% | 400 |
|
|
2016
Q4 | $957K | Buy |
+20,000
| New | +$957K | 0.12% | 237 |
|
|
2016
Q2 | – | Sell |
-8,731
| Closed | -$354K | – | 477 |
|
|
2016
Q1 | $354K | Buy |
+8,731
| New | +$354K | 0.14% | 191 |
|